FDA's history of deeming supplements drugs (or not) in the November 2017 AHPA Report!

AHPA Reports

AHPA's monthly newsletter. Members log in to access issues of the AHPA Report.

FDA’s history of deeming supplements drugs (or not) in the November 2017 AHPA Report!

November 2017 AHPA Report

Published: Tuesday, November 7, 2017

In this issue of AHPA Report:

Special topic:

FDA's history of deeming supplements drugs (or not) by Anthony Young, Esq., Kleinfeld, Kaplan & Becker LLP and AHPA General Counsel
 

Plus:

  • AHPA publishes guidance on foreign matter limits in herbal ingredients

  • AHPA updates guidance on regulatory, liability implications for herbal products under Prop 65

  • AHPA presents recommendations for pre-DSHEA dietary ingredient list
    ...and much more!

Print

2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.